(Q47737473)

5 February 2018

title

Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients (English)

1 reference

5 February 2018

0 references

0 references

1 reference

Moises Labrador-Horrillo

object named as

M Labrador-Horrillo

2

0 references

author name string

A Selva-O'Callaghan

1

1 reference

5 February 2018

X Muñoz-Gall

3

1 reference

5 February 2018

X Martínez-Gomez

4

1 reference

5 February 2018

J Majó-Masferrer

5

1 reference

5 February 2018

R Solans-Laque

6

1 reference

5 February 2018

C P Simeon-Aznar

7

1 reference

5 February 2018

F Morell-Brotard

8

1 reference

5 February 2018

M Vilardell-Tarrés

9

1 reference

5 February 2018

publication date

1 January 2005

1 reference

5 February 2018

published in

Lupus

1 reference

5 February 2018

volume

14

1 reference

5 February 2018

issue

7

1 reference

5 February 2018

page(s)

534-542

1 reference

5 February 2018

Lung fibrosis: new classifications and therapy

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Interstitial lung disease in polymyositis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Polymyositis-dermatomyositis-associated interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

The absorption of carbon monoxide by the lungs during breath-holding

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Respiratory failure due to muscle weakness in inflammatory myopathies: maintenance therapy with home mechanical ventilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Successful treatment of alveolar hypoventilation due to dermatomyositis with anti-tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Clinical and serological aspects of patients with anti-Jo-1 antibodies--an evolving spectrum of disease manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Idiopathic inflammatory myopathy with diffuse alveolar damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Refractory polymyositis responding to infliximab: extended follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Treatment of myositis with etanercept (Enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

Tacrolimus in refractory polymyositis with interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2158OA

10.1191/0961203305LU2158OA

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018